Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-α1 and traditional medicine preparation

In China, liver fibrosis in most patients resulted from the viruses of hepatitis B. Both anti-virus and anti-fibrosis should be considered in designing a program for the treatment of liver fibrosis. Therefore, 40 cases of liver fibros is due to hepatitis B were treated by using IFN-α1 and traditional medicinal preparations from February 1994 to April 1996. Good curative effect was achieved.